Effect of diltiazem, a moderate CYP3A inhibitor, on the pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein inhibitor, in healthy subjects.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples